FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

370893003: Crisantaspase (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1209618019 Erwinia asparaginase en Synonym Active Entire term case sensitive SNOMED CT core module
1228873015 Crisantaspase en Synonym Active Entire term case insensitive SNOMED CT core module
1228874014 Erwinia L-asparaginase en Synonym Active Entire term case sensitive SNOMED CT core module
3686364014 Crisantaspase (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Crisantaspase Is a Asparaginase false Inferred relationship Existential restriction modifier
Crisantaspase Has disposition Hydrolase true Inferred relationship Existential restriction modifier
Crisantaspase Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Crisantaspase Is a Drug allergen false Inferred relationship Existential restriction modifier
Crisantaspase Is a Enzyme agent false Inferred relationship Existential restriction modifier
Crisantaspase Is a Substance with hydrolase mechanism of action true Inferred relationship Existential restriction modifier
Crisantaspase Is a Protein true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Has active ingredient False Crisantaspase Inferred relationship Existential restriction modifier
Product containing crisantaspase (medicinal product) Has active ingredient True Crisantaspase Inferred relationship Existential restriction modifier 1
Crisantaspase poisoning of undetermined intent Causative agent False Crisantaspase Inferred relationship Existential restriction modifier 1
Allergy to crisantaspase Causative agent False Crisantaspase Inferred relationship Existential restriction modifier
Intentional crisantaspase overdose Causative agent True Crisantaspase Inferred relationship Existential restriction modifier 1
Crisantaspase overdose Causative agent True Crisantaspase Inferred relationship Existential restriction modifier 1
Crisantaspase overdose of undetermined intent Causative agent False Crisantaspase Inferred relationship Existential restriction modifier 1
Accidental crisantaspase poisoning Causative agent True Crisantaspase Inferred relationship Existential restriction modifier 1
Intentional crisantaspase poisoning Causative agent True Crisantaspase Inferred relationship Existential restriction modifier 1
Accidental crisantaspase overdose Causative agent True Crisantaspase Inferred relationship Existential restriction modifier 1
Crisantaspase poisoning Causative agent True Crisantaspase Inferred relationship Existential restriction modifier 1
Allergy to crisantaspase Causative agent True Crisantaspase Inferred relationship Existential restriction modifier 1
Crisantaspase Has active ingredient True Crisantaspase Inferred relationship Existential restriction modifier 1
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient False Crisantaspase Inferred relationship Existential restriction modifier 1
Product containing crisantaspase in parenteral dose form (medicinal product form) Has active ingredient True Crisantaspase Inferred relationship Existential restriction modifier 1
Product containing only crisantaspase in parenteral dose form (medicinal product form) Has active ingredient True Crisantaspase Inferred relationship Existential restriction modifier 1
Crisantaspase adverse reaction Causative agent True Crisantaspase Inferred relationship Existential restriction modifier 1
Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Crisantaspase Inferred relationship Existential restriction modifier 1
Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Crisantaspase Inferred relationship Existential restriction modifier 1
Crisantaspase 10,000iu injection (pdr for recon) - product Has active ingredient False Crisantaspase Inferred relationship Existential restriction modifier
Erwinase 10,000iu injection (pdr for recon) Has active ingredient False Crisantaspase Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials Has specific active ingredient True Crisantaspase Inferred relationship Existential restriction modifier
Erwinase 10,000unit powder for solution for injection vials (Porton Biopharma Ltd) Has active ingredient True Crisantaspase Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has active ingredient False Crisantaspase Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 5 vial Has active ingredient False Crisantaspase Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials Has specific active ingredient False Crisantaspase Inferred relationship Existential restriction modifier
Erwinase 10,000unit powder for solution for injection vials (Porton Biopharma Ltd) 20 vial Has active ingredient False Crisantaspase Inferred relationship Existential restriction modifier
Erwinase 10,000unit powder for solution for injection vials (Porton Biopharma Ltd) 5 vial Has active ingredient False Crisantaspase Inferred relationship Existential restriction modifier
Erwinase 10,000unit powder for solution for injection vials (Porton Biopharma Ltd) Has specific active ingredient True Crisantaspase Inferred relationship Existential restriction modifier
Erwinase 10,000unit powder for solution for injection vials (Porton Biopharma Ltd) 20 vial Has specific active ingredient True Crisantaspase Inferred relationship Existential restriction modifier
Erwinase 10,000unit powder for solution for injection vials (Porton Biopharma Ltd) 5 vial Has specific active ingredient True Crisantaspase Inferred relationship Existential restriction modifier
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Has specific active ingredient False Crisantaspase Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has specific active ingredient True Crisantaspase Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 5 vial Has specific active ingredient True Crisantaspase Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start